News
-
-
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Onco-Innovations advances CMC program by initiating analytical method validation for ONC010 API, partnering with Dalton Pharma Services for IND-enabling studies and Phase I clinical development support -